Despite the slowdown in dealmaking, French drugmaker Sanofi on Monday agreed to buy immunology-focused biotech Blueprint Medicines in a deal worth up to $9.5bn and Bristol Myers Squibb struck an up to ...

Alliance Marinomed Biotech AG announces partnership for Budesolv in Switzerland 06.06.2025 / 15:20 CET/CEST The issuer is solely responsible for the content of this announcement.

Merck & Co., Inc. (NYSE: MRK) has explored a potential acquisition of Swiss biotech firm MoonLake Immunotherapeutics in a ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

For decades, things went well for Bellevue Group. But now the sector weakness in biotechs could lead to losses.

Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported ...

As venture funding becomes concentrated in fewer, larger rounds, a biotech with operations in Newton has secured a ...

Switzerland's President Karin Keller-Sutter will travel to Ireland for high-level talks this week, her government said on ...

Though not the first or only study of this type, a new survey reveals the Swiss and international companies where employees ...

Swiss President Karin Keller-Sutter will visit pharma powerhouse Ireland tomorrow for high-level talks ahead of President ...

Swiss biotechnology companies are stepping up expansion and investments in China, eyeing its huge market potential and improved policies to accommodate foreign capital, said executives and ...